S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual ...
Sprout Pharmaceuticals, Inc. (Sprout), a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized ...
Hosted on MSN
What ob-gyns think about the first libido-boosting pill approved for use after menopause
Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire disorder (HSDD)—had no dedicated treatment option available to them. But ...
The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...
Credit: Sprout Pharmaceuticals The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.
Partnership will increase hypoactive sexual desire disorder (HSDD) awareness and expand access to Vyleesi via UpScriptHealth's Women's Health Platform "We are excited to partner with UpScriptHealth, a ...
Verywell Health on MSN
Is There a Female Viagra?
Addyi and Vyleesi are medications for boosting sexual desire in women. Addyi is taken daily at bedtime, while Vyleesi is ...
AURORA, Colorado — Do you ask your patients about their sexual health? Many providers do not broach the topic — whether because they lack the time, feel awkward, or their patients have other, more ...
Please provide your email address to receive an email when new articles are posted on . Hypoactive sexual desire disorder is lack of motivation, desire, response or inability to keep interest in sex.
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...
The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images Postmenopause refers to the time period after the person finishes menopause and no longer has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results